Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors

In the published paper¹, errors appeared in Figure 1D on page 391. In Figure 1D, an incorrect gel image was shown for Bcl-xL in NCI-H1299 cells. Figure 1D has been updated to correct the mistake above. The errors do not affect the conclusions of this article. We apologize for the errors and for any confusion that they may have caused.

• Download figure
• Open in new tab
• Download powerpoint

Figure 1

(C) NSCLC cells were treated with harmine at the indicated concentrations for 24 h, and the expression of the indicated proteins were detected by Western blot. (D) NSCLC cells were treated with 20 µM harmine for 1, 3, 6, 9, and 12 h, and the expression of the indicated proteins was detected by Western blot.

• Received October 29, 2019.
• Accepted February 3, 2020.

• Copyright: © 2022, Cancer Biology & Medicine